The reproductive health devices market includes Endometrial Ablation devices, Female Sterilization devices, Reversible Contraceptive devices and Assisted Reproductive Technology devices. Assisted Reproductive Technology (ART refers to reproductive health procedures that treat subfertile or infertile women or men such that pregnancy is more easily achieved. GlobalData uses proprietary data and analytics to provide a comprehensive report on the assisted reproductive technology devices devices market, including market shares of different players within Israel. Buy the latest report here.
Smarter leaders trust GlobalData
In 2021, GlobalData’s Market Model methodology determined that the leading player in the assisted reproductive technology devices market in Israel was Vitrolife followed by CooperSurgical, Cook Medical, FUJIFILM Irvine Scientific and Corning.
Two prominent techniques analyzed in this market are in vitro fertilization (IVF) and intrauterine insemination (IUI).
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the assisted reproductive technology devices devices market within Israel was expected to be over $6m in 2021.
For the latest complete market share analysis of assisted reproductive technology devices device market in Israel, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
